Skip to content

TELA Bio, Inc.

Public company
Headquarters
MALVERN, Pennsylvania
Ticker
TELA
CIK
0001561921

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

5
2 appointments, 3 departures

Last event

Aug 31, 2026
Executive appointmentprincipal financial officer appointed: Heather Getz

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
principal financial officerHeather GetzAug 31, 2026Appointed
CEOAntony KoblishAug 13, 2026Departed
CEOAntony KoblishAug 4, 2026Departed
member of the BoardAntony KoblishAug 4, 2026Departed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    principal financial officer appointed: Heather Getz

    Heather Getz was named principal financial officer of TELA Bio, Inc.. The company reported the change in an 8-K that cites Item 5.02.

    Role: principal financial officer

    Source: SEC 8-K, filed Aug 31, 2026

  2. Executive departure

    CEO departs: Antony Koblish

    Antony Koblish, Chief Executive Officer of TELA Bio, Inc., departs the role, effective August 3, 2026. The company reported the change in an 8-K/A that cites Item 5.02.

    Role: Chief Executive Officer

    Source: SEC 8-K, filed Aug 13, 2026

  3. Executive departure

    CEO departs: Antony Koblish

    Antony Koblish, Chief Executive Officer and principal executive officer of TELA Bio, Inc., leaves the role, effective August 3, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer and principal executive officer

    Source: SEC 8-K, filed Aug 4, 2026

  4. Executive departure

    member of the Board departs: Antony Koblish

    Antony Koblish, member of the Board of TELA Bio, Inc., resigns the role, effective August 3, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Aug 4, 2026

  5. Executive appointment

    CEO appointed: Heather Getz

    Heather Getz was named Chief Executive Officer and principal executive officer of TELA Bio, Inc., effective August 3, 2026. Heather Getz succeeds Antony Koblish. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer and principal executive officer

    Source: SEC 8-K, filed Aug 4, 2026

Last verified Nov 8, 2026